Cablegate: Turkish Patent Institute On Pharmaceuticals

This record is a partial extract of the original cable. The full text of the original cable is not available.





E.O. 12958: N/A
SUBJECT: Turkish Patent Institute on Pharmaceuticals
IPR Issues

Ref: (A) Ankara 839 (B) State 19340

(C) Finston/Sirotic Email 3/04/05

1. (SBU) Summary: The President of the Turkish Patent
Institute supports the idea of patent linkage and will
work on a system to ensure that the Health Ministry was
informed of valid patents for pharmaceuticals. He
defended Turkey's new data exclusivity regulation and
stated that there is no prospect of providing pipeline
protection. End Summary.

2. (SBU) In a March 8 meeting, Econoff raised a range of
intellectual property concerns, including patent
linkage, the January 2005 data exclusivity regulation,
and pipeline protection, with Yusuf Balci, President of
the Turkish Patent Institute (TPI). Econoff related
that the Health Ministry had told us a system was in
place to ensure that the Ministry was informed of valid
patents prior to approving applications for marketing
generic drugs (ref A). Balci responded that TPI
recently sent the Ministry a list of valid
pharmaceuticals patents, but acknowledged that there is
no established mechanism for updating this list. During
the meeting, Balci consulted with TPI staff on various
ways of doing this. He said he would follow up to
implement such a mechanism.

3. (SBU) Econoff delivered ref (B) points on
deficiencies in Turkey's new data exclusivity
regulation. Balci, who appeared to be unfamiliar with
some of the details of the regulation, said that the new
policy represented a compromise between the demands of
research-based and generic producers. However, he said
that future changes in the policy should not be ruled

4. (SBU) Econoff also informed Balci that the USG was
assessing U.S. industry submissions on intellectual
property protection in the context of the Special 301
review. Econoff highlighted PhRMA's assertion that
members' intellectual property-related losses amount to
nearly USD 900 million annually, mostly due to lack of
pipeline protection (ref C). Econoff stated that the
USG supported TRIPS-plus IPR protection, including
pipeline, and asked Balci for his views on this. Balci
replied that Turkey would not implement pipeline
protection because of legal prohibitions on retroactive
application and because it was not required by the TRIPS

5. (SBU) Noting that the U.S. and Turkey took opposing
sides on other IPR issues, including traditional
knowledge and geographical indications, Balci urged the
USG to factor in other views, particularly from the
developing world, on these matters. Econoff responded
that the USG IPR policy has been responsive to
developing country concerns, highlighting particularly
U.S. leadership on the issue of TRIPS and public health
emergencies. Edelman

© Scoop Media

World Headlines


UN News: ‘Things Have To Change’ Canada’s Trudeau Declares Amid COVID-19 Pandemic

The COVID-19 pandemic has revealed that the world must change, as multilateral systems established decades ago are not working as they should, Prime Minister Justin Trudeau of Canada told the UN General Assembly on Friday. “The world is in crisis, and ... More>>

Assange's Hearing: Latest Observations From Court

Despite severe restrictions on observers, Reporters Without Borders (RSF) is the only NGO that has gained access to the hearing, and we’ve managed to monitor proceedings on most days. We will continue to do so whenever possible. Yesterday I was in court ... More>>

OHCHR: Stranded Migrants Need Safe And Dignified Return – UN Migrant Workers Committee

The UN Committee on Migrant Workers has today called on governments to take immediate action to address the inhumane conditions of migrant workers who are stranded in detention camps and ensure they can have an orderly, safe and dignified return to ... More>>

USA: Investors ‘freaking’ Over Possible Contested Outcome Of Election: Poll

A disputed result in November’s U.S. presidential election is now the number one concern for investors – even ahead of a second wave of Covid-19 – according to a new global survey. The poll carried out by deVere Group, one of the world’s largest ... More>>